# A Study to Evaluate Safety, Tolerability and Pharmacokinetics of Orally Administered TIX100 in Healthy Subjects

> **NCT07675590** · PHASE1 · RECRUITING · sponsor: **TIXiMED, Inc.** · enrollment: 18 (estimated)

## Conditions studied

- Health Adult Subjects
- Obesity & Overweight

## Interventions

- **DRUG:** TIX100
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07675590
- **Lead sponsor:** TIXiMED, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-06-22
- **Primary completion:** 2026-10
- **Final completion:** 2026-12
- **Target enrollment:** 18 (ESTIMATED)
- **Last updated:** 2026-10-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07675590

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07675590, "A Study to Evaluate Safety, Tolerability and Pharmacokinetics of Orally Administered TIX100 in Healthy Subjects". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07675590. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*